CLTS — Earth Life Sciences Share Price
- $0.10m
- $0.15m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.02 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -9.89% | ||
Return on Equity | -20.8% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Earth Life Sciences Inc. is a Canada-based development stage company. The Company is focused on the transportation software market and digital healthcare services through the mode of online ordering and offline service.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- September 30th, 2022
- Incorporated
- November 2nd, 2001
- Public Since
- December 10th, 2003
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 999,891,599
- Address
- 7000 Cote De Liesse, Suite #8, MONTREAL, H4T 1E7
- Web
- https://earthlifesciences.net/
- Phone
- +1 5143738411
- Auditors
- MICHAEL GILLESPIE & ASSOCIATES, PLLC
Upcoming Events for CLTS
Similar to CLTS
1606
Pink Sheets on Nasdaq
2U
Pink Sheets on Nasdaq
Ablaze Technologies
Pink Sheets on Nasdaq
Accelerated Technologies Holding
Pink Sheets on Nasdaq
Acorn Energy
Pink Sheets on Nasdaq
FAQ
As of Today at 20:50 UTC, shares in Earth Life Sciences are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Earth Life Sciences last closed at $0.00 and the price had moved by +9900% over the past 365 days. In terms of relative price strength the Earth Life Sciences share price has outperformed the S&P500 Index by +8256.11% over the past year.
There is no consensus recommendation for this security.
Find out moreEarth Life Sciences does not currently pay a dividend.
Earth Life Sciences does not currently pay a dividend.
Earth Life Sciences does not currently pay a dividend.
To buy shares in Earth Life Sciences you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Earth Life Sciences had a market capitalisation of $0.10m.
Here are the trading details for Earth Life Sciences:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CLTS
Based on an overall assessment of its quality, value and momentum Earth Life Sciences is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Earth Life Sciences. Over the past six months, its share price has outperformed the S&P500 Index by +9318.49%.
As of the last closing price of $0.00, shares in Earth Life Sciences were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Earth Life Sciences PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Earth Life Sciences' management team is headed by:
- Han Lin - PRE
- Angelo Marino - DRC